Dietary Phaseolus vulgaris extract alleviated diet-induced obesity, insulin resistance and hepatic steatosis and alters gut microbiota composition in mice

Journal of Functional Foods

Volumn 20, Issue , 2016, Pages 236-244

  Song, Haizhao ^a,b   Han, Wen ^a   Yan, Fujie ^a   Xu, Dongdong ^a   Chu, Qiang ^a   Zheng, Xiaodong ^a,b  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Gut microbiota; Hepatic steatosis; Insulin resistance; Obesity; Phaseolus vulgaris extract

Indexed keywords

EID: 84953391412     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2015.10.022     Document Type: Article

References (49)

1. Anhe F.F., Roy D., Pilon G., Dudonne S., Matamoros S., Varin T.V., Garofalo C., Moine Q., Desjardins Y., Levy E., Marette A. A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice. Gut 2015, 64:872-883.
2. Axling U., Olsson C., Xu J., Fernandez C., Larsson S., Strom K., Ahrne S., Holm C., Molin G., Berger K. Green tea powder and Lactobacillus plantarum affect gut microbiota, lipid metabolism and inflammation in high-fat fed C57BL/6J mice. Nutrition & Metabolism (Lond) 2012, 9:105.
3. Baboota R.K., Bishnoi M., Ambalam P., Kondepudi K.K., Sarma S.M., Boparai R.K., Podili K. Functional food ingredients for the management of obesity and associated co-morbidities - A review. Journal of Functional Foods 2013, 5:997-1012.
4. Baintner K., Kiss P., Pfuller U., Bardocz S., Pusztai A. Effect of orally and intraperitoneally administered plant lectins on food consumption of rats. Acta Physiologica Hungarica 2003, 90:97-107.
5. Boivin M., Zinsmeister A.R., Go V.L.W., Dimagno E.P. Effect of a purified amylase inhibitor on carbohydrate-metabolism after a mixed meal in healthy humans. Mayo Clinic Proceedings 1987, 62:249-255.
6. Cani P.D., Neyrinck A.M., Fava F., Knauf C., Burcelin R.G., Tuohy K.M., Gibson G.R., Delzenne N.M. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 2007, 50:2374-2383.
7. Carai M.A., Fantini N., Loi B., Colombo G., Riva A., Morazzoni P. Potential efficacy of preparations derived from Phaseolus vulgaris in the control of appetite, energy intake, and carbohydrate metabolism. Diabetes Metab Syndr Obes 2009, 2:145-153.
8. Celleno L., Tolaini M.V., D'Amore A., Perricone N.V., Preuss H.G. A Dietary supplement containing standardized Phaseolus vulgaris extract influences body composition of overweight men and women. International Journal of Medical Sciences 2007, 4:45-52.
9. Charlton M. Nonalcoholic fatty liver disease: A review of current understanding and future impact. Clinical Gastroenterology and Hepatology 2004, 2:1048-1058.
10. Dembinska-Kiec A., Mykkanen O., Kiec-Wilk B., Mykkanen H. Antioxidant phytochemicals against type 2 diabetes. British Journal of Nutrition 2008, 99 E Suppl 1:ES109-ES117.
11. Duncan S.H., Belenguer A., Holtrop G., Johnstone A.M., Flint H.J., Lobley G.E. Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces. Applied and Environmental Microbiology 2007, 73:1073-1078.
12. Espin J.C., Garcia-Conesa M.T., Tomas-Barberan F.A. Nutraceuticals: Facts and fiction. Phytochemistry 2007, 68:2986-3008.
13. Everard A., Cani P.D. Diabetes, obesity and gut microbiota. Best Practice & Research in Clinical Gastroenterology 2013, 27:73-83.
14. Everard A., Lazarevic V., Derrien M., Girard M., Muccioli G.G., Neyrinck A.M., Possemiers S., Van Holle A., Francois P., de Vos W.M., Delzenne N.M., Schrenzel J., Cani P.D. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes 2011, 60:2775-2786.
15. Fantini N., Cabras C., Lobina C., Colombo G., Gessa G.L., Riva A., Donzelli F., Morazzoni P., Bombardelli E., Carai M.A. Reducing effect of a Phaseolus vulgaris dry extract on food intake, body weight, and glycemia in rats. Journal of Agricultural and Food Chemistry 2009, 57:9316-9323.
16. Fei N., Zhao L. An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice. ISME Journal 2013, 7:880-884.
17. Folch J., Lees M., Sloane Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissues. Journal of Biological Chemistry 1957, 226:497-509.
18. Guida S., Venema K. Gut microbiota and obesity: Involvement of the adipose tissue. Journal of Functional Foods 2015, 14:407-423.
19. Haenen D., Zhang J., Souza da Silva C., Bosch G., van der Meer I.M., van Arkel J., van den Borne J.J., Perez Gutierrez O., Smidt H., Kemp B., Muller M., Hooiveld G.J. A diet high in resistant starch modulates microbiota composition, SCFA concentrations, and gene expression in pig intestine. Journal of Nutrition 2013, 143:274-283.
20. Hildebrandt M.A., Hoffmann C., Sherrill-Mix S.A., Keilbaugh S.A., Hamady M., Chen Y.Y., Knight R., Ahima R.S., Bushman F., Wu G.D. High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology 2009, 137:1716-1724.
21. Jones B.V., Begley M., Hill C., Gahan C.G.M., Marchesi J.R. Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:13580-13585.
22. Kalliomaki M., Collado M.C., Salminen S., Isolauri E. Early differences in fecal microbiota composition in children may predict overweight. American Journal of Clinical Nutrition 2008, 87:534-538.
23. Kemperman R.A., Gross G., Mondot S., Possemiers S., Marzorati M., Van de Wiele T., Dore J., Vaughan E.E. Impact of polyphenols from black tea and red wine/grape juice on a gut model microbiome. Food Research International 2013, 53:659-669.
24. Kleiner D.E., Brunt E.M., Van Natta M., Behling C., Contos M.J., Cummings O.W., Ferrell L.D., Liu Y.C., Torbenson M.S., Unalp-Arida A., Yeh M., McCullough A.J., Sanyal A.J. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology (Baltimore, Md.) 2005, 41:1313-1321. Nonalcoholic Steatohepatitis Clinical Research Network.
25. Kotzampassi K., Giamarellos-Bourboulis E.J., Stavrou G. Obesity as a consequence of gut bacteria and diet interactions. ISRN obesity, 2014 2014.
26. Kovatcheva-Datchary P., Arora T. Nutrition, the gut microbiome and the metabolic syndrome. Best Practice & Research in Clinical Gastroenterology 2013, 27:59-72.
27. Kruszynska Y.T., Olefsky J.M. Cellular and molecular mechanisms of non-insulin dependent diabetes mellitus. Journal of Investigative Medicine 1996, 44:413-428.
28. Layer P., Carlson G.L., Dimagno E.P. Partially purified white bean amylase inhibitor reduces starch digestion invitro and inactivates intraduodenal amylase in humans. Gastroenterology 1985, 88:1895-1902.
29. Layer P., Zinsmeister A.R., Dimagno E.P. Effects of decreasing intraluminal amylase activity on starch digestion and postprandial gastrointestinal function in humans. Gastroenterology 1986, 91:41-48.
30. Liou A.P., Paziuk M., Luevano J.M., Machineni S., Turnbaugh P.J., Kaplan L.M. Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Science Translational Medicine 2013, 5.
31. Liu R.H. Health benefits of fruit and vegetables are from additive and synergistic combinations of phytochemicals. American Journal of Clinical Nutrition 2003, 78:517S-520S.
32. Maccioni P., Colombo G., Riva A., Morazzoni P., Bombardelli E., Gessa G.L., Carai M.A. Reducing effect of a Phaseolus vulgaris dry extract on operant self-administration of a chocolate-flavoured beverage in rats. British Journal of Nutrition 2010, 104:624-628.
33. Mai V. Dietary modification of the intestinal microbiota. Nutrition Reviews 2004, 62:235-242.
34. Popkin B.M., Kim S., Rusev E.R., Du S., Zizza C. Measuring the full economic costs of diet, physical activity and obesity-related chronic diseases. Obesity Reviews 2006, 7:271-293.
35. Pusztai A., Bardocz S., Ewen S.W. Uses of plant lectins in bioscience and biomedicine. Frontiers in Bioscience-Landmark 2008, 13:1130-1140.
36. Pusztai A., Grant G., Buchan W.C., Bardocz S., de Carvalho A.F.F.U., Ewen S.W.B. Lipid accumulation in obese Zucker rats is reduced by inclusion of raw kidney bean (Phaseolus vulgaris) in the diet. British Journal of Nutrition 1998, 79:213-221.
37. Rondanelli M., Giacosa A., Orsini F., Opizzi A., Villani S. Appetite control and glycaemia reduction in overweight subjects treated with a combination of two highly standardized extracts from Phaseolus vulgaris and Cynara scolymus. Phytotherapy Research 2011, 25:1275-1282.
38. Santacruz A., Marcos A., Warnberg J., Marti A., Martin-Matillas M., Campoy C., Moreno L.A., Veiga O., Redondo-Figuero C., Garagorri J.M., Azcona C., Delgado M., Garcia-Fuentes M., Collado M.C., Sanz Y., Grp E.S. Interplay between weight loss and gut microbiota composition in overweight adolescents. Obesity 2009, 17:1906-1915.
39. Shin N.R., Lee J.C., Lee H.Y., Kim M.S., Whon T.W., Lee M.S., Bae J.W. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut 2014, 63:727-735.
40. Spadafranca A., Rinelli S., Riva A., Morazzoni P., Magni P., Bertoli S., Battezzati A. Phaseolus vulgaris extract affects glycometabolic and appetite control in healthy human subjects. British Journal of Nutrition 2013, 109:1789-1795.
41. Tormo M.A., Gil-Exojo I., Romero de Tejada A., Campillo J.E. Hypoglycaemic and anorexigenic activities of an alpha-amylase inhibitor from white kidney beans (Phaseolus vulgaris) in Wistar rats. British Journal of Nutrition 2004, 92:785-790.
42. Tormo M.A., Gil-Exojo I., Romero de Tejada A., Campillo J.E. White bean amylase inhibitor administered orally reduces glycaemia in type 2 diabetic rats. British Journal of Nutrition 2006, 96:539-544.
43. Udani J., Singh B.B. Blocking carbohydrate absorption and weight loss: A clinical trial using a proprietary fractionated white bean extract. Alternative Therapies in Health and Medicine 2007, 13:32-37.
44. Xu J., Gordon J.I. Honor thy symbionts. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:10452-10459.
45. Xu J., Mahowald M.A., Ley R.E., Lozupone C.A., Hamady M., Martens E.C., Henrissat B., Coutinho P.M., Minx P., Latreille P., Cordum H., Van Brunt A., Kim K., Fulton R.S., Fulton L.A., Clifton S.W., Wilson R.K., Knight R.D., Gordon J.I. Evolution of symbiotic bacteria in the distal human intestine. PLoS Biology 2007, 5:e156.
46. Zang L., Shimada Y., Kawajiri J., Tanaka T., Nishimura N. Effects of Yuzu (Citrus junos Siebold ex Tanaka) peel on the diet-induced obesity in a zebrafish model. Journal of Functional Foods 2014, 10:499-510.
47. Zhang H., DiBaise J.K., Zuccolo A., Kudrna D., Braidotti M., Yu Y., Parameswaran P., Crowell M.D., Wing R., Rittmann B.E., Krajmalnik-Brown R. Human gut microbiota in obesity and after gastric bypass. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:2365-2370.
48. Zhang X., Zhao Y., Xu J., Xue Z., Zhang M., Pang X., Zhang X., Zhao L. Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats. Scientific Reports 2015, 5:14405.
49. Zhao L. The gut microbiota and obesity: From correlation to causality. Nature Reviews. Microbiology 2013, 11:639-647.